-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U3iRbP/ZorBqp/kKdWB3r+67EPFHUjKCo8JcMX4ix/hdEN6Cd3H5mKRdGfe0gsUr U626Ts1DAR6im+vKA4qetA== 0000950117-02-002370.txt : 20021003 0000950117-02-002370.hdr.sgml : 20021003 20021003141453 ACCESSION NUMBER: 0000950117-02-002370 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20021002 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20021003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES INC CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 02780807 BUSINESS ADDRESS: STREET 1: 6140 STONERIDGE MALL RD STREET 2: STE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9254603600 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 8-K 1 a33486.txt THE COOPER COMPANIES ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2002 THE COOPER COMPANIES, INC. (Exact name of registrant as specified in its charter) Delaware 1-8597 94-2657368 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorporation)
6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588 (Address of principal executive offices) (925) 460-3600 (Registrant's telephone number, including area code) ================================================================================ ITEM 5. Other Events. On October 2, 2002, The Cooper Companies, Inc. issued a press release announcing that CooperVision, Inc., its contact lens business, had been notified by its marketing partner in Japan, Rohto Pharmaceutical Company, Inc. that the Japanese Ministry of Health and Welfare has cleared Rohto to market a variety of CVI's lenses. A copy of this release is attached and incorporated by reference. Internet addresses in the release are for information purposes only and are not intended to be hyperlinks to other Cooper Companies information. ITEM 7. Financial Statements and Exhibits. (c) Exhibits. Exhibit No. Description - ------- ----------- 99.1 Press Release dated October 2, 2002 of The Cooper Companies, Inc. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE COOPER COMPANIES, INC. By /s/ Stephen C. Whiteford -------------------------------- Stephen C. Whiteford Vice President and Corporate Controller (Principal Accounting Officer) Dated: October 3, 2002 EXHIBIT INDEX
Exhibit Sequentially No. Description Numbered Page - ------- ----------- ------------- 99.1 Press Release dated October 2, 2002 of The Cooper Companies, Inc.
EX-99 3 ex99-1.txt EXHIBIT 99.1 COO The Listed Cooper NYSE Companies NEWS RELEASE - ------------ CONTACT: Norris Battin The Cooper Companies, Inc. ir@coopercompanies.com ---------------------- FOR IMMEDIATE RELEASE COOPER COMPANIES' UNIT CLEARED TO MARKET DISPOSABLE CONTACT LENSES IN JAPAN --------------------------------------------------------------------------- LAKE FOREST, Calif., October 2, 2002 -- The Cooper Companies, Inc., (NYSE:COO) said today that CooperVision, Inc. (CVI), its contact lens business, has been notified by its marketing partner in Japan, Rohto Pharmaceutical Company, Inc., that the Japanese Ministry of Health and Welfare has cleared Rohto to market CVI's disposable spherical, aspheric and toric contact lenses made from the methafilcon A polymer. Rohto will market CVI's lenses in Japan under the Rohto i.Q brand name. CVI plans to ship lenses to Rohto during Cooper's first fiscal quarter, which ends on January 31, 2003, and Rohto expects to begin selling CVI lenses shortly after that. CVI will receive manufacturing profit from the products it sells to Rohto. Rohto currently markets CVI's spherical and toric contact lenses that wearers replace quarterly or yearly. Because they are easier to care for, planned replacement and disposable contact lenses that are changed every day, every two weeks or monthly, have become the most popular products worldwide. In Japan, daily disposable lenses and two-week lenses are the most common modalities. With approximately 10 million contact lens wearers, Japan is the second largest contact lens market in the world after the United States, and soft lenses continue to grow in popularity. CVI estimates that the total market for soft contact lenses in Japan today is about $650 million, about the size of the total European market, compared with about $1.2 billion in the United States. The Japanese market is currently divided equally between daily and two-week disposable lenses and is currently growing at about 9% per year compared with about 3% in the United States and 7% in Europe. The incidence of myopia (near-sightedness) and astigmatism (an irregularly shaped cornea that can cause blurred vision) in Japan is the highest in the world. About 75% of the myopic population also requires an astigmatic correction, compared with about 50% in the United States. Those with higher levels of astigmatism, about half the astigmatic population, are potential candidates for toric lenses. The market in Japan for toric lenses, CVI's most important product line, is proportionately smaller than in the United States, but is expected to grow rapidly as newer generations of toric lenses are introduced. CVI is the world's largest manufacturer of soft toric contact lenses. Rohto Pharmaceutical Company, Ltd. is a leading manufacturer of contact lens care products, holding, according to their estimates, a 40% share of the market for non-pharmaceutical ophthalmic products in Japan. Rohto's total revenue approaches $600 million, most originating in Pacific Rim countries. Non-prescription ophthalmic products account for about one-third of its worldwide revenue. Rohto plans to capitalize on their well-established eyecare and contact lens care brands and use a combination of professional and consumer promotion to introduce CVI's new contact lens products. Rohto's shares are publicly traded in Japan. It has major manufacturing facilities in Japan, the United States and other facilities in over 20 countries. Rhoto's World Wide Web address is www.rohto.co.jp. Forward Looking Statements Some of the information included in this news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements regarding anticipated growth in our revenue, anticipated market conditions and results of operations. To identify forward-looking statements look for words like "believes," "expects," "may," "will," "should," "seeks," "intends," "plans," "estimates" or "anticipates" and similar words or phrases. Discussions of strategy, plans or intentions often contain forward-looking statements. These, and all forward-looking statements, necessarily depend on assumptions, data or methods that may be incorrect or imprecise. Events, among others, that could cause actual results and future actions to differ materially from those described in forward-looking statements include major changes in business conditions, a major disruption in the operations of our manufacturing facilities, new competitors or technologies, the impact of an undetected virus on our computer systems, acquisition integration delays or costs, increases in interest rates, foreign currency exchange exposure, investments in research and development and other start-up projects, dilution to earnings per share from acquisitions or issuing stock, regulatory issues, changes in tax laws, significant environmental cleanup costs above those already accrued, litigation costs including any related settlements, cost of business divestitures, the requirement to provide for a significant liability or to write off a significant asset, changes in accounting principles or estimates, and other factors described in our Securities and Exchange Commission filings, including the "Business" section in our Annual Report on Form 10-K for the year ended October 31, 2001. We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law. About Cooper The Cooper Companies, Inc. and its subsidiaries develop, manufacture and market specialty healthcare products. Corporate offices are in Lake Forest and Pleasanton, Calif. A toll free interactive telephone system at 1-800-334-1986 provides stock quotes, recent press releases and financial data. Cooper's World Wide Web address is www.coopercos.com. CooperVision, Inc., markets a broad range of contact lenses for the vision care market. Headquartered in Lake Forest, Calif., it manufactures in Huntington Beach, Calif., Rochester, N.Y., Norfolk, Va., Adelaide, Australia, Farnborough and Hamble, England, Madrid, Spain and Toronto. Its Web address is www.coopervision.com. CooperSurgical, Inc., with operations in Trumbull, Conn., Fort Atkinson, Wis., Malmo, Sweden, Montreal and Berlin, markets medical devices, diagnostic products, surgical instruments and accessories for the women's healthcare market. Its World Wide Web address is www.coopersurgical.com. ### -----END PRIVACY-ENHANCED MESSAGE-----